Insider trading on July 24, 2026
32 insiders at 29 companies bought $98.4M of their own stock on the open market, across 48 transactions. The largest was Aghazadeh Behzad, Director, 10% Owner, buying $35M of Scribe Therapeutics, Inc. (SCTX).
13 chief executives bought: Huang Jack Jiajia at COE, Goh Kok E at CCHH, Semple Christopher James at Crestline Lending Solutions, LLC and 10 more.
Insiders sold $117.4M across 151 open-market sales. That is 1.2× the value bought. Selling routinely outweighs buying, because most executive pay is delivered in stock.
Open-market purchases
Code P only — insiders spending their own money, largest first.
Open-market sales
Pre-arranged 10b5-1 trades are marked.